IRWD
Ironwood Pharmaceuticals Inc
4.20$
-1.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +1,474.2% | +55.1% | +4.5% | -33.0% | -43.5% | +22.7% | |
| – | -5.7% | -3.2% | +29.8% | -2.7% | -60.8% | -36.1% | -57.9% | -5.5% | +11.1% | +27.7% | -6.5% | |
| – | -2.7% | +14.7% | +15.7% | +30.0% | -28.9% | -0.3% | -28.5% | +21.4% | +18.3% | -6.7% | -42.2% | |
| – | -7.9% | +79.7% | -120.5% | – | -13.8% | -78.4% | -1,752.0% | – | – | – | – | |
| – | – | – | – | – | -1,412.9% | – | – | -84.1% | +300.0% | -93.4% | +5,265.4% | |
| – | +14.4% | +2,473.6% | -96.0% | +104.7% | -16.6% | -74.4% | -85.6% | -48.7% | +100.7% | -48.0% | -76.1% | |
| – | -83.8% | +1,841.2% | – | -41.3% | -112.5% | -83.5% | -85.6% | -48.7% | +754,545.6% | -100.0% | -76.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -62.8% | -64.9% | +6.2% | +21.6% | -57.6% | +36.4% | -230.1% | +423.8% | -100.0% | – | – | |
| – | +530.5% | +106.8% | – | -121.4% | – | -842.6% | +0.0% | +0.0% | – | -138.3% | -100.0% | |
| – | +43.7% | -101.4% | – | +51.6% | -103.9% | – | -124.5% | +5,120.9% | – | -138.6% | – | |
| – | – | -210.9% | – | -33.0% | -103.3% | – | +38.6% | -86.0% | -1,668.4% | – | – | |
| – | – | – | – | – | – | +4,622.7% | +56.7% | +4.6% | -33.1% | -43.5% | +22.8% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.